Abstract
Genistein, a major component of soybean isoflavone, has been shown to inhibit cell proliferation and enhance apoptosis in cancer cells. Accumulating bodies of evidence suggest that genistein is expected to synergistically promote the anti-proliferative effects of chemotherapeutic agents on neoplasia without toxicity. At molecular biological levels, a wide array of genistein targets has been characterized so far. These include transcription factors such as NF-kappaB and several signaling pathways. Genistein also reduces oxidative stress. When all the information is taken together, genistein could be applied together with chemotherapeutic agents to cure neurodegenerative disease as well as neoplasia. In this review, recent findings, of molecular actions of genistein, especially during the past three years, have been summarized to explore the potential therapeutic usage of genistein for human disease.
Keywords: Genistein, NF-kappaB, apoptosis, signal transduction, oxidative stress, chemotherapeutics
Current Signal Transduction Therapy
Title: Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use
Volume: 3 Issue: 3
Author(s): Kenichi Yoshida
Affiliation:
Keywords: Genistein, NF-kappaB, apoptosis, signal transduction, oxidative stress, chemotherapeutics
Abstract: Genistein, a major component of soybean isoflavone, has been shown to inhibit cell proliferation and enhance apoptosis in cancer cells. Accumulating bodies of evidence suggest that genistein is expected to synergistically promote the anti-proliferative effects of chemotherapeutic agents on neoplasia without toxicity. At molecular biological levels, a wide array of genistein targets has been characterized so far. These include transcription factors such as NF-kappaB and several signaling pathways. Genistein also reduces oxidative stress. When all the information is taken together, genistein could be applied together with chemotherapeutic agents to cure neurodegenerative disease as well as neoplasia. In this review, recent findings, of molecular actions of genistein, especially during the past three years, have been summarized to explore the potential therapeutic usage of genistein for human disease.
Export Options
About this article
Cite this article as:
Yoshida Kenichi, Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use, Current Signal Transduction Therapy 2008; 3 (3) . https://dx.doi.org/10.2174/157436208785699703
DOI https://dx.doi.org/10.2174/157436208785699703 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Functional Genomics Approaches in Cancer Research
Current Genomics Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with <sup>177</sup>Lu and Conjugated to Peptides
Current Radiopharmaceuticals Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases
Current Medicinal Chemistry Enzymes To Die For: Exploiting Nucleotide Metabolizing Enzymes for Cancer Gene Therapy
Current Gene Therapy Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism Nitric Oxide and Cancer Therapy: The Emperor has NO Clothes
Current Pharmaceutical Design Development of New Potential Anticancer Metal Complexes Derived from 2-Hydrazinobenzothiazole
Mini-Reviews in Medicinal Chemistry VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Systemic Delivery of Nanoformulations of Anti-cancer Drugs with Therapeutic Potency in Animal Models of Cancer
Current Cancer Therapy Reviews Subject Index to Volume 4
Current Drug Metabolism Antisense Strategies in Therapy of Gliomas
Current Signal Transduction Therapy Heme Oxygenase-1 and Breast Cancer Resistance Protein Protect Against Hemeinduced Toxicity
Current Pharmaceutical Design Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2
Current Drug Delivery Current Status of Newer Carbapenems
Current Medicinal Chemistry Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics
Current Medicinal Chemistry Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Synthesis and 188Re Radiolabelling of Dendrimer Polyamide Amine (PAMAM) Folic Acid Conjugate
Medicinal Chemistry Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6
Current Drug Research Reviews New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design